Searchable abstracts of presentations at key conferences in endocrinology

ea0077p232 | Neuroendocrinology and Pituitary | SFEBES2021

Dramatic resolution of a pituitary macroadenoma: non-functioning or prolactin-secreting?

Mohamed Mousa Abdusalam , Ashraf Tanveer , Lessan Nader

Background: Non-functioning pituitary tumours can be associated with a modestly elevated prolactin. Response to dopamine agonist therapy in such cases is unusual. Large macroprolactinomas are associated with much higher prolactin levels and respond well to dopamine agonists.Case: We report a 41-year-old man with a pituitary macroadenoma associated with an elevated prolactin of around 2000mIU/l who developed marked resolution in his pituitary MRI images r...

ea0086p168 | Adrenal and Cardiovascular | SFEBES2022

Inclisiran for the treatment of hypercholesterolemia in clinical settings

Iqbal Sajid , Sabbour Hani , Ashraf Tanveer , Buckley Adam

Background: Inclisiran is the first clinically available small interfering RNA (siRNA)-based treatment, has been shown to reduce pro-atherogenic lipoproteins in patients with or without familial hypercholesterolemia (FH), diabetes mellitus (DM), or atherosclerotic cardiovascular disease (ASCVD), but has not been evaluated in Middle Eastern populations.Methods: Retrospective review of patients initiating inclisiran treatment for any indication at our cent...

ea0073aep161 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

An analysis of flash glucose monitoring (FGM) data on insulin-treated patients with diabetes: Effects of COVID-19 lockdown

Ashraf Tanveer , Helal Radwa , Majeed Maria , Lessan Nader

IntroductionFollowing the WHO declaration of COVID-19 as a pandemic and as many countries around the world, the United Arab Emirates government introduced gradual measures to stop the spread of the virus placing the country in a state of almost complete-lockdown. We report the impact of these restrictions on glucose control in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) on insulin therapy.Methods<p class="abst...

ea0065p178 | Metabolism and Obesity | SFEBES2019

Glycaemic response to a mixed meal challenge: does camel milk preload confer an advantage?

Moriarty Maura , Buckley Adam , Ashraf Tanveer , Barakat Maha T , Lessan Nader

Camel milk provides a modest portion of the overall global milk share but is an important source of protein in arid regions. Perceived health benefits include anti-diabetic properties attributed to its unique composition. We hypothesise that exogenous insulin present in camel milk mediates a hypoglycaemic effect. In a randomised, double blind crossover study, eleven normoglycaemic individuals were allocated to receive a 300 kcal pre-load of camel milk or cow milk ten minutes p...

ea0070ep143 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Lipoatrophy in a patient with type 1 diabetes: Genetic or immunological?

Ashraf Tanveer , Awad Nisreen , Suliman Sara , Helal Radwa , Naqvi Safdar , Lessan Nader

We report the case of a 28-year-old Emirati lady with type 1 diabetes (weight 51 kg, BMI 20.82 kg/m2) diagnosed at 3 years of age who presented to our centre with problems at her insulin injection sites. She had poor glycaemic control and her diabetes was complicated by retinopathy; other past medical history included vitamin D deficiency. All her seven siblings had diabetes and were on insulin; both parents had type 2 diabetes.In 2017, she wa...